Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events … Read full Trend Edge analysis →
Sector: Healthcare
Industry: Drug Manufacturers-General
Exchange: NASDAQ
IPO Date: June 17, 1983
Headquarters: One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
Hidden Gem: Yes — undiscovered relative to its market cap tier
Founder-Led: No
Key Metrics
Current Price
$442.24
Market Cap
$234.65B
Float
539.2M
Shares Outstanding
541.0M
P/E (Forward)
19.72
P/E (TTM)
27.47
Price/Sales (TTM)
6.16
vs. Analyst Target
-12.2% to analyst PT
Profit Margin
22.95%
Operating Margin (TTM)
35.55%
Revenue (TTM)
$38.09B
Earnings Growth (YoY)
64.90%
Dividend Rate
10.1%
Analyst Target Price
$388.48 (32 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$25.42B
$7.26B
$19.27B
$13.00B
2021
$25.98B
$5.89B
$19.52B
$11.30B
2022
$26.32B
$6.55B
$19.92B
$12.17B
2023
$28.19B
$6.72B
$19.74B
$7.90B
2024
$33.42B
$4.09B
$20.57B
$13.36B
2025
$36.74B
$7.71B
$26.01B
$16.90B
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
$9.56B
$3.22B
Dec 2025
$9.90B
$1.33B
Mar 2026
$8.62B
$1.82B
Jun 2026
$10.05B
$2.38B
Ownership & Float
Insider Ownership
0.2%
Institutional Ownership
85.1%
Short Float
2.5%
% of All Funds Holding
35.60%
Number of Funds Holding
3,131
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$393.11
Near-term / short-term trend
Weekly
40-Week SMA
$357.73
Medium-term trend
Weekly
80-Week SMA
$326.24
Cyclical trend (business cycle)
Weekly
200-Week SMA
$296.53
Secular trend (multi-year)
Monthly
10-Month SMA
$362.72
Near-term monthly trend
Monthly
20-Month SMA
$327.70
Medium-term monthly trend
Monthly
40-Month SMA
$304.65
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Amgen Inc
(AMGN) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.